Influenza Virus Net is the web resource for anyone interested in influenza and flu pandemics. Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the influenza viruses), that affects humans, birds and other mammals. The virus spreads easily from person to person. Influenza circulates worldwide and can affect anybody in any age group. Influenza causes annual epidemics that peak during winter in temperate regions. Influenza is a serious public health problem that causes severe illnesses and deaths for higher risk populations. The most common symptoms of the disease are chills, fever, sore throat, muscle pains, severe headache, coughing, weakness/fatigue and general discomfort. Sore throat, fever and coughs are the most frequent symptoms. In more serious cases, influenza causes pneumonia, which can be fatal, particularly for the young and the elderly. An influenza epidemic can take an economic toll through lost workforce productivity, and strain health services. Vaccination is the most effective way to prevent infection.

The objectives of Influenza Virus Net are to be the public and professional information resource for influenza and to serve as a network in the exchange of information and news related to influenza.

• Double threat of COVID-19 and influenza - The Lancet
  Thu, 22 Oct 2020 22:30 GMT
• Last season's flu vaccine provided substantial protection for children - Healio
  Sat, 24 Oct 2020 18:40 GMT
• 1918 Spanish flu pandemic seems familiar in 2020 - Chattanooga Times Free Press
  Sat, 24 Oct 2020 22:15 GMT
• Common Questions About Influenza - University of Utah Health Care
  Sat, 24 Oct 2020 08:44 GMT
• The 2020 Flu Season’s Delayed Start is Good News - Precision Vaccinations
  Fri, 23 Oct 2020 18:29 GMT
• Virginia Tech professor compares COVID-19 with Spanish Influenza - WSLS 10
  Fri, 23 Oct 2020 13:27 GMT
• COVID-19 and Influenza: A Q&A with Drs. Roshni Mathew and Katya Gerwein - Stanford Children's Health Blog - Stanford Children's Health
  Tue, 06 Oct 2020 07:00 GMT
• Bracing for a collision between influenza and COVID-19 | TheHill - The Hill
  Fri, 23 Oct 2020 12:30 GMT
• Flu Season Never Came to the Southern Hemisphere - Scientific American
  Wed, 30 Sep 2020 07:00 GMT
• Plant-Derived Influenza Vaccine Shows Tolerability, Immunogenicity Potential - MD Magazine
  Thu, 15 Oct 2020 13:03 GMT
• WHO Recommends Flu Shots to Prevent Surge of Influenza During Pandemic - Voice of America
  Fri, 25 Sep 2020 07:00 GMT
• Updated influenza vaccine advice targets protection of elderly and health workers - UN News
  Fri, 25 Sep 2020 07:00 GMT
• New study highlights risks associated with the sequential infection of influenza followed by COVID-19 - Medical Xpress
  Thu, 15 Oct 2020 07:00 GMT
• BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate - BioSpace
  Fri, 23 Oct 2020 15:16 GMT
• Cocrystal Pharma Provides Update on Influenza A Program - GlobeNewswire
  Mon, 19 Oct 2020 12:05 GMT

• PRO/ALL> New in IJID (10): October 2020
  Fri, 23 Oct 2020 09:38:10 -0400
  COVID-19, Not Yet Classified, Dengue, Japanese Encephalitis, Hepatitis, HIV/AIDS, Hand, Foot and Mouth Disease, Tuberculosis, Schistosomiasis, Influenza, Carbapenem-resistant enterobacteriaceae (CRE) -- Worldwide/Unknown
  ITP following vaccination
  Paula David, Yehuda Shoenfeld
  Int J Infect Dis. 2020; 99(Oct): 243-244
  
  A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa
  Robert Colebunders, Joseph Nelson Siewe Fodjo, Guido Vanham, Rafael Van den Bergh
  Int J Infect Dis. 2020; 99(Oct): 482-484
  
  Coronavirus (COVID-19)

• Continental-scale dynamics of avian influenza in U.S. waterfowl are driven by demography, migration, and temperature.
  
• The Effect of TLR4 Blockade on Some Indicators of Systemic Inflammatory Response to Proteus mirabilis LPS in Rats.
  
• Impact of systematic factors on the outbreak outcome of novel coronavirus disease (COVID-19) in China.
  
• TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.
  
• Cardiac troponin elevation in patients with influenza virus infections.
  
• Influenza A Viruses: Understanding Human Host Determinants.
  
• Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach.
  
• Semisynthetic Cardenolides Acting as Antiviral Inhibitors of Influenza A Virus Replication by Preventing Polymerase Complex Formation.